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mn this issue of iJACC, 2 papers are published on
risk stratification with coronary computed tomo-
graphic angiography (CTA) in the evaluation of
post-coronary artery bypass surgery (CABG) pa-
tients (1) and in the evaluation of acute chest
pain in the emergency department (2). The devel-
opment of high quality evidence with CTA is
now consistent with comparative evidence with
more conventional diagnostic imaging modalities.
Amazingly, this body of evidence has amassed
over a very short period of time by the CTA
community as a response to queries for high qual-
ity data to guide clinical decision making. A re-
view of the published evidence reveals several
hundred papers on the prognostic accuracy of
CTA with most reported in the past 3 to 4 years.
The rapidity of development for CTA evi-
dence is hard to imagine when other imaging
techniques required decades to accumulate a
body of evidence. Just a few short years ago, it
was not uncommon to see CTA reports in 100
or fewer patients (3). Current reports frequently in-
clude multicenter registries reporting thousands
of patients including data from the CONFIRM
(COronary CT Angiography EvaluatioN For Clini-
cal Outcomes: An InteRnational Multicenter) regis-
try including more than 20,000 patients (4). This is
substantial accomplishment on the part of clinical
nvestigators who have dedicated research efforts to-
ard providing clinically valuable information.
Not only has the computed tomography com-
unity put forth an astounding number of high
uality diagnostic trials and prognostic registries
ut they have taken a leadership role in develop-
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A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine,
New York, New York.ng and validating strategies for reduction in radi-
tion dose that may be uniformly applied. It is
ow routinely possible for a CTA examination to
e performed in 3 mSv. These technological
evelopments and continuous quality initiatives
ave focused on reductions in effective doses with
TA while maintaining image quality in order to
rovide enhanced patient safety (5,6).
The evidence clearly has accrued that CTA is
n established imaging modality with proven abil-
ties to diagnose and risk stratify significant and
evere obstructive coronary artery disease with un-
olding evidence in the field of nonobstructive
therosclerosis (7–11). The rapid development of
his evidence base will provide a challenge for
usy clinicians and readers of this journal to stay
urrent with the coronary CTA evidence. Recent
nd updated meta-analysis (12), appropriate use
riteria (13), and clinical practice guidelines will
e helpful to synthesize this evidence base for the
ardiovascular community.
Although ongoing trials are underway to com-
are CTA with functional stress testing, more
ork is required to understand the role of nonin-
asive versus invasive anatomic imaging to guide
edical and surgical management. Perhaps the most
mportant contribution to the literature will be the
pplication of CTA as a gatekeeper to invasive coro-
ary angiography in order to reduce the normal cor-
nary angiography rate, promote cost efficiency, and
educe the rate of ad hoc percutaneous coronary in-
ervention. This latter trial is currently under devel-
pment (CONSERVE [COmputed Tomographic
Ngiography for SElective Cardiac Catheterization:
elation to CardioVascular Outcomes, Cost Effec-
iveness and Quality of Life] trial) and as an opti-
al venue for CTA to showcase its strength iniagnosing the extent and severity of coronary
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566disease and, importantly, does not eliminate the
need for selective, complementary information
on functional ischemia.
This issue of iJACC highlights the achieve-
ments of CTA with reports such as those from
Chow et al. (1) and Schlett et al. (2), their re-tomography before and after implemen-
1
1
1
phy angiography aBlankstein (14) and Schoenhagen et al. (15) and a
State-of-the-Art review by Voros et al. (16). By
all standards, CTA is now a mature diagnostic
strategy and can be referred to as an established
diagnostic imaging modality whose wealth of evi-
dence can provide an effective means to safelyspective Editorial Comments by O’Gara and guide clinical decision making.1
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